{"id":"https://openalex.org/W1997586838","doi":"https://doi.org/10.7314/apjcp.2013.14.3.2131","title":"Salvage Chemotherapy in Recurrent Platinum-Resistant or Refractory Epithelial Ovarian Cancer with Carboplatin and Distearoylphosphatidylcholine Pegylated Liposomal Doxorubicin (Lipo-Dox\u00ae)","display_name":"Salvage Chemotherapy in Recurrent Platinum-Resistant or Refractory Epithelial Ovarian Cancer with Carboplatin and Distearoylphosphatidylcholine Pegylated Liposomal Doxorubicin (Lipo-Dox\u00ae)","publication_year":2013,"publication_date":"2013-03-30","ids":{"openalex":"https://openalex.org/W1997586838","doi":"https://doi.org/10.7314/apjcp.2013.14.3.2131","mag":"1997586838","pmid":"https://pubmed.ncbi.nlm.nih.gov/23679331"},"language":"en","primary_location":{"id":"doi:10.7314/apjcp.2013.14.3.2131","doi":"https://doi.org/10.7314/apjcp.2013.14.3.2131","is_oa":true,"landing_page_url":"https://doi.org/10.7314/apjcp.2013.14.3.2131","pdf_url":"http://koreascience.or.kr:80/article/JAKO201321365237885.pdf","source":{"id":"https://openalex.org/S121579133","display_name":"Asian Pacific Journal of Cancer Prevention","issn_l":"1513-7368","issn":["1513-7368","2476-762X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319060","host_organization_name":"West Asia Organization for Cancer Prevention","host_organization_lineage":["https://openalex.org/P4310319060"],"host_organization_lineage_names":["West Asia Organization for Cancer Prevention"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Pacific Journal of Cancer Prevention","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://koreascience.or.kr:80/article/JAKO201321365237885.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084596036","display_name":"Nipon Khemapech","orcid":"https://orcid.org/0000-0002-6976-6835","observed_orcids":["https://orcid.org/0000-0002-6976-6835"]},"institutions":[{"id":"https://openalex.org/I158708052","display_name":"Chulalongkorn University","ror":"https://ror.org/028wp3y58","country_code":"TH","type":"education","lineage":["https://openalex.org/I158708052"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"Nipon Khemapech","raw_affiliation_strings":["Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. niponkhe@yahoo.com","Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. niponkhe@yahoo.com","institution_ids":["https://openalex.org/I158708052"]},{"raw_affiliation_string":"Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand","institution_ids":["https://openalex.org/I158708052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037385574","display_name":"Shina Oranratanaphan","orcid":"https://orcid.org/0000-0003-3738-7061","observed_orcids":["https://orcid.org/0000-0003-3738-7061"]},"institutions":[{"id":"https://openalex.org/I158708052","display_name":"Chulalongkorn University","ror":"https://ror.org/028wp3y58","country_code":"TH","type":"education","lineage":["https://openalex.org/I158708052"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"S. Oranratanaphan","raw_affiliation_strings":["Gynecologic Oncology Division , Department of Obstetrics and Gynecology , Faculty of Medicine , Chulalongkorn University , Bangkok , Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Oncology Division , Department of Obstetrics and Gynecology , Faculty of Medicine , Chulalongkorn University , Bangkok , Thailand","institution_ids":["https://openalex.org/I158708052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043688320","display_name":"Wichai Termrungruanglert","orcid":"https://orcid.org/0000-0003-3510-0047","observed_orcids":["https://orcid.org/0000-0003-3510-0047"]},"institutions":[{"id":"https://openalex.org/I158708052","display_name":"Chulalongkorn University","ror":"https://ror.org/028wp3y58","country_code":"TH","type":"education","lineage":["https://openalex.org/I158708052"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"W. Termrungruanglert","raw_affiliation_strings":["Gynecologic Oncology Division , Department of Obstetrics and Gynecology , Faculty of Medicine , Chulalongkorn University , Bangkok , Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Oncology Division , Department of Obstetrics and Gynecology , Faculty of Medicine , Chulalongkorn University , Bangkok , Thailand","institution_ids":["https://openalex.org/I158708052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020407348","display_name":"Ruangsak Lertkhachonsuk","orcid":"https://orcid.org/0000-0003-3516-0584","observed_orcids":["https://orcid.org/0000-0003-3516-0584"]},"institutions":[{"id":"https://openalex.org/I158708052","display_name":"Chulalongkorn University","ror":"https://ror.org/028wp3y58","country_code":"TH","type":"education","lineage":["https://openalex.org/I158708052"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"R. Lertkhachonsuk","raw_affiliation_strings":["Gynecologic Oncology Division , Department of Obstetrics and Gynecology , Faculty of Medicine , Chulalongkorn University , Bangkok , Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Oncology Division , Department of Obstetrics and Gynecology , Faculty of Medicine , Chulalongkorn University , Bangkok , Thailand","institution_ids":["https://openalex.org/I158708052"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051369023","display_name":"A. Vasurattana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I158708052","display_name":"Chulalongkorn University","ror":"https://ror.org/028wp3y58","country_code":"TH","type":"education","lineage":["https://openalex.org/I158708052"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"A. Vasurattana","raw_affiliation_strings":["Gynecologic Oncology Division , Department of Obstetrics and Gynecology , Faculty of Medicine , Chulalongkorn University , Bangkok , Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Oncology Division , Department of Obstetrics and Gynecology , Faculty of Medicine , Chulalongkorn University , Bangkok , Thailand","institution_ids":["https://openalex.org/I158708052"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I158708052"],"apc_list":{"value":200,"currency":"USD","value_usd":200},"apc_paid":{"value":200,"currency":"USD","value_usd":200},"fwci":4.4277,"has_fulltext":true,"cited_by_count":19,"citation_normalized_percentile":{"value":0.92928613,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"14","issue":"3","first_page":"2131","last_page":"2135"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/salvage-chemotherapy","display_name":"salvage chemotherapy","score":0.9229999780654907},{"id":"https://openalex.org/keywords/epithelial-ovarian-cancer","display_name":"epithelial ovarian cancer","score":0.8429999947547913},{"id":"https://openalex.org/keywords/fallopian-tube-cancer","display_name":"fallopian tube cancer","score":0.9769999980926514},{"id":"https://openalex.org/keywords/platinum-resistance","display_name":"platinum resistance","score":0.7369999885559082},{"id":"https://openalex.org/keywords/refractory-ovarian-cancer","display_name":"refractory ovarian cancer","score":0.7689999938011169},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.8429999947547913},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.7829999923706055},{"id":"https://openalex.org/keywords/distearoylphosphatidylcholine","display_name":"distearoylphosphatidylcholine","score":0.878000020980835},{"id":"https://openalex.org/keywords/pegylated-liposomal-doxorubicin","display_name":"pegylated liposomal doxorubicin","score":0.9779999852180481},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6919999718666077},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7860000133514404},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9879999756813049},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.7080000042915344},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.7139999866485596},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7829999923706055}],"concepts":[{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.849305272102356},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8337117433547974},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6050417423248291},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.575727105140686},{"id":"https://openalex.org/C2777249960","wikidata":"https://www.wikidata.org/wiki/Q4818922","display_name":"Fallopian tube cancer","level":4,"score":0.5714852213859558},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5296860933303833},{"id":"https://openalex.org/C2775883341","wikidata":"https://www.wikidata.org/wiki/Q1233836","display_name":"Fallopian tube","level":2,"score":0.5161577463150024},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.4702063202857971},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.454234778881073},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4121793508529663},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4104407727718353},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40401846170425415},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3984798192977905},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3911142945289612},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.22355198860168457},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005185","descriptor_name":"Fallopian Tube Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005185","descriptor_name":"Fallopian Tube Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D005185","descriptor_name":"Fallopian Tube Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010713","descriptor_name":"Phosphatidylcholines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018262","descriptor_name":"Adenocarcinoma, Clear Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018262","descriptor_name":"Adenocarcinoma, Clear Cell","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D018262","descriptor_name":"Adenocarcinoma, Clear Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018284","descriptor_name":"Cystadenocarcinoma, Serous","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018284","descriptor_name":"Cystadenocarcinoma, Serous","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D018284","descriptor_name":"Cystadenocarcinoma, Serous","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D060787","descriptor_name":"Neoplasm Grading","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.7314/apjcp.2013.14.3.2131","doi":"https://doi.org/10.7314/apjcp.2013.14.3.2131","is_oa":true,"landing_page_url":"https://doi.org/10.7314/apjcp.2013.14.3.2131","pdf_url":"http://koreascience.or.kr:80/article/JAKO201321365237885.pdf","source":{"id":"https://openalex.org/S121579133","display_name":"Asian Pacific Journal of Cancer Prevention","issn_l":"1513-7368","issn":["1513-7368","2476-762X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319060","host_organization_name":"West Asia Organization for Cancer Prevention","host_organization_lineage":["https://openalex.org/P4310319060"],"host_organization_lineage_names":["West Asia Organization for Cancer Prevention"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Pacific Journal of Cancer Prevention","raw_type":"journal-article"},{"id":"pmid:23679331","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23679331","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Pacific journal of cancer prevention : APJCP","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7314/apjcp.2013.14.3.2131","doi":"https://doi.org/10.7314/apjcp.2013.14.3.2131","is_oa":true,"landing_page_url":"https://doi.org/10.7314/apjcp.2013.14.3.2131","pdf_url":"http://koreascience.or.kr:80/article/JAKO201321365237885.pdf","source":{"id":"https://openalex.org/S121579133","display_name":"Asian Pacific Journal of Cancer Prevention","issn_l":"1513-7368","issn":["1513-7368","2476-762X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319060","host_organization_name":"West Asia Organization for Cancer Prevention","host_organization_lineage":["https://openalex.org/P4310319060"],"host_organization_lineage_names":["West Asia Organization for Cancer Prevention"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Pacific Journal of Cancer Prevention","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1997586838.pdf","grobid_xml":"https://content.openalex.org/works/W1997586838.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W1504144622","https://openalex.org/W1516107827","https://openalex.org/W1819818791","https://openalex.org/W1825188255","https://openalex.org/W1878670617","https://openalex.org/W1940922428","https://openalex.org/W1945760023","https://openalex.org/W1960327677","https://openalex.org/W1968187769","https://openalex.org/W1972160506","https://openalex.org/W1987593270","https://openalex.org/W2009038500","https://openalex.org/W2017246589","https://openalex.org/W2017801815","https://openalex.org/W2021555497","https://openalex.org/W2024414263","https://openalex.org/W2026361533","https://openalex.org/W2037064988","https://openalex.org/W2038647187","https://openalex.org/W2044421413","https://openalex.org/W2051787604","https://openalex.org/W2052846363","https://openalex.org/W2070636593","https://openalex.org/W2073197917","https://openalex.org/W2082992386","https://openalex.org/W2110316435","https://openalex.org/W2118878458","https://openalex.org/W2121298692","https://openalex.org/W2133506440","https://openalex.org/W2160684474","https://openalex.org/W2164168201","https://openalex.org/W2169794253","https://openalex.org/W2170179169","https://openalex.org/W2202035925","https://openalex.org/W2245111413","https://openalex.org/W2328421677","https://openalex.org/W2395678656"],"related_works":["https://openalex.org/W2136642976","https://openalex.org/W2104371545","https://openalex.org/W1850734520","https://openalex.org/W1968187769","https://openalex.org/W1983790945","https://openalex.org/W167835567","https://openalex.org/W2404423444","https://openalex.org/W2021651415","https://openalex.org/W2534209694","https://openalex.org/W2135568547"],"abstract_inverted_index":{"BACKGROUND:":[0],"To":[1],"evaluate":[2],"the":[3,17,70,106,152,179,187,198,274],"efficacy":[4,90],"and":[5,73,84,91,99,124,133,163,182,193,215,236,254,265,286],"safety":[6],"of":[7,19,38,93,112,140,148,176,200,225,262,292],"distearoylphosphatidylcholine":[8],"pegylated":[9],"liposomal":[10],"doxorubicin":[11],"(DPLD)":[12],"combined":[13,278],"with":[14,43,116,126,145,279,294],"carboplatin":[15,44,134,280],"for":[16,45,137,290],"treatment":[18,227,291],"platinum":[20,117],"resistant":[21,118],"or":[22,28,48,119,232,270,297],"refractory":[23,120,298],"epithelial":[24,121,299],"ovarian":[25,122,300],"cancer":[26,51,123],"(EOC)":[27],"fallopian":[29,49,127],"tube":[30,50,128],"cancer.":[31,301],"MATERIALS":[32],"AND":[33],"METHODS:":[34],"A":[35,110],"retrospective":[36],"analysis":[37],"women":[39],"who":[40],"received":[41],"DPLD":[42,132],"recurrent":[46,295],"EOC":[47],"in":[52,186,207,217,239],"King":[53],"Chulalongkorn":[54],"Memorial":[55],"Hospital":[56],"Thailand":[57],"from":[58,69],"January":[59],"2006":[60],"to":[61],"August":[62],"2011":[63],"was":[64,170,190],"conducted.":[65],"Patients":[66],"were":[67,87,95,103,130,135,266],"identified":[68],"medical":[71],"records":[72],"data":[74],"on":[75],"demographic":[76],"factors,":[77],"stage,":[78],"histology,":[79],"surgical":[80],"findings,":[81],"cytoreduction":[82],"status,":[83],"prior":[85],"chemotherapies":[86],"abstracted.":[88],"The":[89,166],"toxicity":[92,289],"DPLD/carboplatin":[94],"evaluated.":[96],"Progression-free":[97],"(PFS)":[98],"overall":[100,167,184],"survival":[101,185],"(OS)":[102],"estimated":[104],"by":[105],"Kaplan-Meier":[107],"method.":[108],"RESULTS:":[109],"total":[111,147],"65":[113,153],"patients,":[114,155],"64":[115],"1":[125,231,269],"cancer,":[129],"enrolled.":[131],"given":[136],"an":[138],"average":[139],"4.46":[141,191],"cycles":[142],"per":[143],"patient":[144],"a":[146,173],"273":[149],"cycles.":[150],"Among":[151],"evaluable":[154],"0%":[156],"achieved":[157],"CR,":[158],"7.69%":[159],"PR,":[160],"15.4%":[161],"SD":[162],"76.%":[164],"PD.":[165],"response":[168],"rate":[169],"23.1%.":[171],"With":[172],"median":[174,180,183],"follow-up":[175],"27.4":[177],"months,":[178],"progression-free":[181],"36":[188],"patients":[189,293],"months":[192,195],"8.76":[194],"respectively.":[196],"In":[197],"aspect":[199],"side":[201],"effects,":[202],"palmar-plantar":[203],"erythrodysesthesia":[204],"(PPE)":[205],"occurred":[206,238],"33.3%":[208],"(Grade":[209,219,241,248,256],"I":[210,220,242,249,257],"22.2%,":[211],"Grade":[212,222,230,244,251,259,268],"II":[213,223,245,252,260],"11.1%)":[214],"mucositis":[216],"41.7%":[218],"27.8%,":[221],"13.9%)":[224],"all":[226,229],"cycles,":[228],"2.":[233,271],"Anemia,":[234],"leukopenia":[235],"thrombocytopenia":[237],"58.3%":[240],"41.7%,":[243],"16.7%),":[246],"66.7%":[247],"47.2%,":[250],"19.4%),":[253],"22.2%":[255],"16.6%,":[258],"5.56%)":[261],"cycle":[263],"respectively,":[264],"mostly":[267],"CONCLUSIONS:":[272],"DPLD,":[273],"second-generation":[275],"PLD":[276],"drug":[277],"every":[281],"4":[282],"weeks,":[283],"is":[284],"effective":[285],"has":[287],"low":[288],"platinum-resistant":[296]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}